Philadelphia, PA, United States of America

Valli Venkata Srikanth Yellamelli

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valli Venkata Srikanth Yellamelli: Innovator in Cancer Research

Introduction

Valli Venkata Srikanth Yellamelli is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of cancer research through his innovative work. His research focuses on developing compounds that can potentially treat various types of cancer.

Latest Patents

Yellamelli holds a patent for "Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same." This patent provides compounds that serve as ACSS2 inhibitors, which are useful in treating, ameliorating, and preventing certain types of cancer. His work in this area highlights the potential for new therapeutic approaches in oncology.

Career Highlights

Yellamelli is affiliated with The Wistar Institute, a prominent research institution known for its focus on cancer and infectious diseases. His role at the institute allows him to collaborate with other leading scientists and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Zachary Schug and Joseph Salvino. Their collaborative efforts enhance the research environment at The Wistar Institute and contribute to the advancement of cancer treatment methodologies.

Conclusion

Valli Venkata Srikanth Yellamelli is a dedicated inventor whose work in developing ACSS2 inhibitors represents a significant advancement in cancer research. His contributions are paving the way for innovative treatments that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…